Life Sciences 

Attorneys at Halloran Farkas + Kittila  practice in a wide-variety of areas to service the needs of both corporate and individual clients with respect to business and litigation matters.  The following highlights just a few of the areas in which HFK Law focuses its practice.  More information about our collective and individual experience can be found in About Us.

HFK Law attorneys are counselors to business professionals as their outside general and special counsel, providing guidance on corporategovernance, advice on responding to  litigation risk, and even providing  forecasting with respect to complex litigation.  


We strive to efficiently serve our clients.  We have big firm experience, but small firm nimbleness.  


For general questions, please contact us at (302) 257-2011.

With regulatory concerns being a critical and necessary component of daily business life, HFK Law is well positioned to service its clients before federal regulatory bodies through its D.C. office.  HFK Law partner Peter Farkas has vast experience before the International Trade Commission (Section 337 Proceedings), and antitrust experience as a former attorney with the DOJ's antitrust division. Mike Halloran is the former Counselor to the Chairman and Deputy Chief of Staff of the Securities and Exchange Commission and, as a former General Counsel of Bank of America, has extensive financial institution and securities regulatory experience.  Edgar Asebey has over 20 years of experience representing clients before the Food and Drug Administration (FDA), U.S. Department of Agriculture (USDA), Federal Trade Commission (FTC) and U.S. Customs and Border Protection (CBP).

Regulatory

Corporate

Litigation

Advisory

HFK Law partner  Peter Farkas  has regularly represented clients in high stakes intellectual property disputes, both nationally and internationally. HFK Law attorneys regularly appear in other U.S. jurisdictions through local counsel and serve as Delaware counsel in patent litigation in the United States District Court for the District of Delaware. HFK Law regularly advises start-ups with respect to their intellectual property concerns. Michael Keller has regularly represented domestic and international clients on patent, trademark, and copyright matters and related transactions.

Practices

Whether it's a complex corporate governance issue or a future M&A or other transaction, HFK Law partners have experience in shepherding both the start-up and the Fortune 500 clients through complex transactional matters as outside general counsel to these businesses. HFK Law partner  Mike Halloran  has helped to shepherd both new and experienced business leaders through the most complex matters.  We can guide you through the complexities of corporate finance, board responsibilities, securities law requirements, and help to paper the deal correctly and efficiently.


For more information about HFK Law's board representation, Click Here.

HFK Law attorneys have served as first chair litigation attorneys on high stakes corporate and complex litigation matters.  HFK Law partners  Ted Kittila  and  Jay McMillan  practice before the Delaware Court of Chancery, the Delaware Supreme Court, the Delaware Superior Court, as well as the Federal Court in the District of Delaware and other courts nationally, handling issues as varied as fiduciary disputes, derivative litigation, contract disputes, and receivership litigation. 

Intellectual Property

At HFK Law, we understand that the Life Sciences industry is not only filled with promise, but also filled with risk.  We offer comprehensive services so that your company can manage risk and maximize opportunity.  HFK’s Life Science practice is comprised of a multidisciplinary team of attorneys led by Michael Keller and Edgar Asebey which focuses on providing practical, cost-effective solutions to your life science business challenges. We provide expert legal, regulatory, business, and strategic guidance to your company in the areas of: patent strategy, prosecution & litigation; technology transfer & licensing, FDA approval, compliance and enforcement defense; life science and healthcare transactions; and  M & A and venture finance.  Our attorneys have been involved with the development of products, creation of companies and the negotiation of deals for pharmaceutical, biotech, medical device and diagnostics. We have also counseled clients on FDA regulation related to 510(k), PMA, BLA, IND, NDA and ANDA filings.